Efficacy of bevacizumab-based treatment in early-onset treatment-naive metastatic colorectal cancer patients: An ARCAD database analysis

被引：0
|
作者：
Jin, Zhaohui
Dixon, Jesse G.
Hubbard, Joleen M.
Eng, Cathy
Lieu, Christopher Hanyoung
Fiskum, Jack
Saltz, Leonard B.
Hurwitz, Herbert I.
Venook, Alan P.
Schmoll, Hans-Joachim
Fuchs, Charles S.
Hecht, J. Randolph Randolph
Cremolini, Chiara
Diaz-Rubio, Eduardo
Punt, Cornelis J. A.
Tebbutt, Niall C.
Heinemann, Volker
Yoshino, Takayuki
De Gramont, Aimery
Shi, Qian
机构：
[1] Univ Iowa, Iowa City, IA 52242 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin, Rochester, MN USA
[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[5] Univ Colorado, Ctr Canc, Aurora, CO USA
[6] Mem Sloan Kettering Canc Ctr, Dept Colorectal Oncol, 1275 York Ave, New York, NY 10021 USA
[7] Duke Univ, Sch Med, Durham, NC USA
[8] Univ Calif San Francisco, San Francisco, CA 94143 USA
[9] Martin Luther Univ Halle Wittenberg, Halle, Germany
[10] Yale Canc Ctr, New Haven, CT USA
[11] Smilow Canc Hosp, New Haven, CT USA
[12] UCLA, Los Angeles, CA USA
[13] Azienda Osped Univ, Pisana Ospedale Santa Chiara, Pisa, Italy
[14] Hosp Clin Univ San Carlos, Madrid, Spain
[15] Amsterdam UMC, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands
[16] Austin Hlth, Wellness & Res Ctr, Olivia Newton John Canc, Heidelberg, Vic, Australia
[17] Univ Hosp Munich, LMU Munich, Munich, Germany
[18] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[19] Franco British Inst, Levallois Perret, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
101
引用
收藏
页数：3
相关论文
共 50 条
  • [11] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Ocvirk, Janja
    Rebersek, Martina
    Benedik, Jernej
    Volk, Neva
    ANNALS OF ONCOLOGY, 2011, 22 : v96 - v96
  • [12] BASELINE CEA SERUM LEVELS PREDICT THE EFFICACY OF BEVACIZUMAB-BASED TREATMENT IN ADVANCED COLORECTAL CANCER
    Prager, G.
    Zielinski, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 221 - 221
  • [13] Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
    Scartozzi, M.
    Giampieri, R.
    Maccaroni, E.
    Del Prete, M.
    Faloppi, L.
    Bianconi, M.
    Galizia, E.
    Loretelli, C.
    Belvederesi, L.
    Bittoni, A.
    Cascinu, S.
    BRITISH JOURNAL OF CANCER, 2012, 106 (05) : 799 - 804
  • [14] Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
    M Scartozzi
    R Giampieri
    E Maccaroni
    M Del Prete
    L Faloppi
    M Bianconi
    E Galizia
    C Loretelli
    L Belvederesi
    A Bittoni
    S Cascinu
    British Journal of Cancer, 2012, 106 : 799 - 804
  • [15] VEGF and eNOS gene polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in patients with metastatic colorectal cancer
    Ulivi, P.
    Passardi, A.
    Marisi, G.
    Casacci, F.
    Scarpi, E.
    Valgiusti, M.
    Calistri, D.
    Del Re, M.
    Frassineti, G. L.
    Amadori, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S563 - S563
  • [16] Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease
    Haberman, Yael
    BenShoshan, Marina
    Di Segni, Ayelet
    Dexheimer, Phillip J.
    Braun, Tzipi
    Weiss, Batia
    Walters, Thomas D.
    Baldassano, Robert N.
    Noe, Joshua D.
    Markowitz, James
    Rosh, Joel
    Heyman, Melvin B.
    Griffiths, Anne M.
    Crandall, Wallace V.
    Mack, David R.
    Baker, Susan S.
    Kellermayer, Richard
    Patel, Ashish
    Otley, Anthony
    Steiner, Steven J.
    Gulati, Ajay S.
    Guthery, Stephen L.
    LeLeiko, Neal
    Moulton, Dedrick
    Kirschner, Barbara S.
    Snapper, Scott
    Avivi, Camila
    Barshack, Iris
    Oliva-Hemker, Maria
    Cohen, Stanley A.
    Keljo, David J.
    Ziring, David
    Anikster, Yair
    Aronow, Bruce
    Hyams, Jeffrey S.
    Kugathasan, Subra
    Denson, Lee A.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (02) : 346 - 360
  • [17] TREATMENT OF STAGE IV EARLY-ONSET COLORECTAL CANCER: A COMPARATIVE ANALYSIS
    Almadi, Faris S.
    Mansell, Jacob G.
    Belkovsky, Mikhael
    Khan, Imran
    Gorgun, Emre
    Sommovilla, Joshua
    Valente, Michael
    Liska, David
    GASTROENTEROLOGY, 2024, 166 (05) : S1766 - S1766
  • [18] Treatment patterns in metastatic early-onset rectal cancer
    Thompson, Nasya
    Waddell, Oliver
    Mccombie, Andrew
    Frizelle, Francis
    Glyn, Ms Tamara
    ANZ JOURNAL OF SURGERY, 2024,
  • [19] Markers to predict the efficacy of bevacizumab in the treatment of metastatic colorectal cancer
    Varol, Umut
    Yildiz, Ibrahim
    Salman, Tarik
    Karabulut, Bulent
    Uslu, Ruchan
    TUMORI JOURNAL, 2014, 100 (04): : 370 - 376
  • [20] Treatment with bevacizumab in patients with metastatic colorectal cancer (mCRC)
    Ocvirk, Janja
    Rebersek, Martina
    Boc, Marko
    Motara, Maja Ebert
    Mesti, Tanja
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345